TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 35.55
0.00 (0.00%)
Aug 26, 2026, 12:47 PM CST
TCI GENE Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 251.39 | 273.61 | 347.54 | 333.86 | 424.02 | 432.22 | |
Revenue Growth | -22.59% | -21.27% | 4.10% | -21.27% | -1.90% | 124.01% |
Cost of Revenue | 106.41 | 121.02 | 143.47 | 159.24 | 180.66 | 192.79 |
Gross Profit | 144.99 | 152.59 | 204.07 | 174.62 | 243.36 | 239.43 |
Selling, General & Admin | 87.22 | 99.83 | 114.17 | 122.98 | 89.93 | 66.4 |
Research & Development | 31.16 | 33.68 | 34.14 | 45.62 | 62.33 | 59.46 |
Operating Expenses | 115.77 | 131.65 | 151.57 | 168.69 | 152.8 | 126.18 |
Operating Income | 29.22 | 20.93 | 52.5 | 5.93 | 90.56 | 113.25 |
Interest Expense | -1.1 | -1.4 | -0.5 | -1.18 | -0.85 | -0.84 |
Interest & Investment Income | 55.99 | 56.9 | 37.81 | 9.67 | 3.64 | 0.23 |
Earnings From Equity Investments | -8.44 | -8.12 | -9.35 | -5.86 | -3.45 | - |
Currency Exchange Gain (Loss) | 0.09 | 0.09 | 0.05 | -0.07 | -0.69 | -0.24 |
Other Non Operating Income (Expenses) | 4.92 | -0.43 | 0.17 | 0.22 | 0.68 | 5.96 |
EBT Excluding Unusual Items | 80.68 | 67.97 | 80.68 | 8.71 | 89.89 | 118.36 |
Gain (Loss) on Sale of Investments | -29.06 | -29.06 | -20.15 | - | - | -1.94 |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | 7.03 | - | 0.24 | 0.01 |
Other Unusual Items | - | - | - | 0.06 | - | - |
Pretax Income | 51.68 | 38.97 | 67.56 | 8.78 | 90.13 | 116.44 |
Income Tax Expense | -0.05 | -0.11 | 11.03 | -8.18 | 15.79 | 24.29 |
Earnings From Continuing Operations | 51.73 | 39.08 | 56.53 | 16.95 | 74.34 | 92.14 |
Minority Interest in Earnings | -1.11 | 1.49 | -0.21 | -5.28 | -2.19 | 0.31 |
Net Income | 50.62 | 40.57 | 56.31 | 11.67 | 72.15 | 92.45 |
Net Income to Common | 50.62 | 40.57 | 56.31 | 11.67 | 72.15 | 92.45 |
Net Income Growth | 41.40% | -27.96% | 382.40% | -83.82% | -21.96% | 158.63% |
Shares Outstanding (Basic) | 27 | 26 | 26 | 26 | 24 | 19 |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 26 | 25 | 20 |
Shares Change | 2.67% | 0.30% | 0.18% | 7.71% | 24.22% | 5.74% |
EPS (Basic) | 1.89 | 1.53 | 2.13 | 0.44 | 2.95 | 4.84 |
EPS (Diluted) | 1.88 | 1.52 | 2.12 | 0.44 | 2.93 | 4.67 |
EPS Growth | 37.61% | -28.30% | 381.82% | -84.98% | -37.26% | 144.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 106.91 | 150.91 | 54.4 | 15.46 | 96.4 | 96.39 |
Free Cash Flow Per Share | 3.98 | 5.67 | 2.05 | 0.58 | 3.92 | 4.87 |
Dividend Per Share | - | - | 2.000 | 1.000 | 2.000 | 2.028 |
Dividend Growth | - | - | 100.00% | -50.00% | -1.36% | - |
Gross Margin | 57.67% | 55.77% | 58.72% | 52.30% | 57.39% | 55.40% |
Operating Margin | 11.62% | 7.65% | 15.11% | 1.78% | 21.36% | 26.20% |
Profit Margin | 20.14% | 14.83% | 16.20% | 3.50% | 17.01% | 21.39% |
Free Cash Flow Margin | 42.53% | 55.16% | 15.65% | 4.63% | 22.73% | 22.30% |
EBITDA | 33.47 | 26.61 | 59.79 | 15.11 | 112.07 | 145.86 |
EBITDA Margin | 13.31% | 9.73% | 17.20% | 4.53% | 26.43% | 33.75% |
D&A For EBITDA | 4.25 | 5.68 | 7.29 | 9.18 | 21.51 | 32.61 |
EBIT | 29.22 | 20.93 | 52.5 | 5.93 | 90.56 | 113.25 |
EBIT Margin | 11.62% | 7.65% | 15.11% | 1.78% | 21.36% | 26.20% |
Effective Tax Rate | - | - | 16.33% | - | 17.52% | 20.86% |